The need for preclinical testing expertise is growing as molecular complexity increases.
Daniel Radiloff
Advertisement
Daniel Radiloff, PhD, is director of Business Development, Pacific BioLabs.
Articles by Daniel Radiloff
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
